1. Easton, Douglas F, Lesueur, Fabienne, Decker, Brennan, Tavtigian, Sean V, Chenevix-Trench, Georgia. 2016. No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing. In Journal of medical genetics, 53, 298-309. doi:10.1136/jmedgenet-2015-103529. https://pubmed.ncbi.nlm.nih.gov/26921362/
2. Ramus, Susan J, Song, Honglin, Dicks, Ed, Pharoah, Paul D P, Gayther, Simon A. 2015. Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer. In Journal of the National Cancer Institute, 107, . doi:10.1093/jnci/djv214. https://pubmed.ncbi.nlm.nih.gov/26315354/
3. Martín-Morales, Lorena, Garre, Pilar, Lorca, Víctor, Castellví-Bel, Sergi, Caldés, Trinidad. 2020. BRIP1, a Gene Potentially Implicated in Familial Colorectal Cancer Type X. In Cancer prevention research (Philadelphia, Pa.), 14, 185-194. doi:10.1158/1940-6207.CAPR-20-0316. https://pubmed.ncbi.nlm.nih.gov/33115781/
4. Moyer, Cassandra L, Ivanovich, Jennifer, Gillespie, Jessica L, Swisher, Elizabeth M, Goodfellow, Paul J. 2019. Rare BRIP1 Missense Alleles Confer Risk for Ovarian and Breast Cancer. In Cancer research, 80, 857-867. doi:10.1158/0008-5472.CAN-19-1991. https://pubmed.ncbi.nlm.nih.gov/31822495/